A 10-year survival update on early-stage extranodal natural killer/T-cell lymphoma with ‘sandwich’ therapy
Authors:
- 28 February 2022
- journal article
- letter
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 61 (5) , 611-614
Abstract
Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive subtype of T/natural killer (NK) cell lymphoma according to the World Health Organization (WHO) classification of tumors [1]. Due ...Keywords
This publication has 9 references indexed in Scilit:
- Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell ProjectThe Lancet Haematology, 2020
- Causes of mortality in cases with extra nodal natural killer/T-cell lymphoma, nasal type: A cohort studyPLOS ONE, 2019
- A phase II prospective study of the “Sandwich” protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphomaOncotarget, 2017
- A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysisThe Lancet Oncology, 2016
- Sequential DICE combined withl-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphomaLeukemia & Lymphoma, 2015
- Five‐year analysis from phase 2 trial of “sandwich” chemoradiotherapy in newly diagnosed, stage IE to IIE , nasal type, extranodal natural killer/T‐cell lymphomaCancer Medicine, 2015
- Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter studyLeukemia, 2015
- Phase 2 trial of “Sandwich” L‐asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T‐cell lymphomaCancer, 2011
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical OutcomesJournal of Clinical Oncology, 2008